Certain statements on this website, including documents posted on, or linked to, this website are about Numinus' current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments and they constitute "forward-looking information" and "forward-looking statements" as defined under applicable Canadian and U.S. Securities Laws (collectively, "forward-looking statements"). The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these words.
Forward-looking statements are based on certain assumptions and estimates made by us in light of the experience and perception of historical trends, current conditions, expected future developments, including projected growth in the integrative mental health industry, and other factors we believe are appropriate and reasonable in the circumstances, but there can be no assurance that such assumptions and estimates will prove to be correct. These assumptions include, but are not limited to: Numinus' ability to generate cash flow from operations and obtain necessary financing on acceptable terms; general economic, financial market, regulatory and political conditions in which Numinus operates remaining the same; Numinus' ability to compete in the integrative mental health industry; Numinus' ability to manage anticipated and unanticipated costs; Numinus' ability to maintain internal controls over financial reporting and disclosure, and procedures; Numinus' ability to attract and retain patients and research subjects; the timely receipt of any required regulatory approvals; Numinus' ability to obtain qualified staff, equipment and services in a timely and cost efficient manner; Numinus' ability to conduct operations in a safe, efficient and effective manner; government regulation of Numinus' activities will remain the same; Numinus' ability to successfully complete trials and studies relating to its treatments and future products; and Numinus' ability to successfully build or sustain partnerships or relationships with key players in the integrative mental health industry; Numinus' ability to operate its business and market its products as intended; Numinus' ongoing compliance with regulatory requirements; no unfavorable publicity or change in consumer perception of Numinus or the psychedelics industry; Numinus' ability to comply with general healthcare regulation requirements; Numinus' ability to obtain and sustain required regulatory certification and licencing; Numinus' ability to comply with provincial, state and federal health care plan payment requirements; Numinus' ability to comply with privacy and data protection laws; Numinus' ability to obtain or register intellectual property rights; Numinus' ability to appropriately manage growth; Numinus' ability to retain and acquire skilled personnel, including key personnel; Numinus' ability to maintain appropriate insurance coverage; Numinus' ability to achieve its stated goals or execute its strategies; Numinus' ability to obtain financing and access to capital; the accuracy of Numinus' estimates and assumptions relating to its critical accounting policies; the adequacy of Numinus' internal controls, including over recently completed acquisitions; and Numinus' ability to comply with reporting issuer requirements under applicable securities laws and stock exchange policies.
The realization of Numinus' forward-looking statements depends on Numinus' business performance which, in turn, is subject to various risks. Many factors could cause Numinus' actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements, including, but are not limited to those affecting the healthcare industry in general and the psychedelics industry in particular, risks affecting Numinus’ business, and certain financial and accounting risks, each of which are more fully described in Numinus’ public disclosure record available on www.sedar.com under its profile.
Although Numinus believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The purpose of the forward-looking statements is to provide the reader with a description of management's expectations regarding Numinus' performance and may not be appropriate for other purposes. Readers should not place undue reliance on forward-looking statements made on this website or the documents posted on, or linked to, this website.
Unless otherwise stated, the forward-looking statements contained on the www.numinus.com and www.investors.numinus.com websites are made as of the date of such post, news release, or document, and the Company has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.